AFP and rhabdomyosarcoma: One of the WHO-specified AFP surveillance indicators requires that at least 10% of stool samples from AFP cases submitted to the laboratory should be positive for non-polio enteroviruses in Human rhabdomyosarcoma (RD) cell cultures [24].